Overview: Mumps IgM TestIntroduction: The Mumps IgM Test detects mumps IgM to diagnose recent infection, causing swelling or fever. Following 2023 CDC guidelines, it uses immunoassay for high specificity, supporting infection screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in serology for patients with suspected acute mumps infection.
Other Names: Mumps IgM Assay, Recent Mumps Test.
FDA Status: Laboratory-developed test (LDT), meeting serology standards for diagnostic accuracy.
Historical Milestone: Mumps IgM testing began in the 1970s with outbreak research. Immunoassay methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects mumps IgM to diagnose recent infection, guides treatment, and evaluates patients with swelling or fever.
Test Parameters: 1. Mumps IgM Antibodies
Pretest Condition: No fasting required. Collect serum or saliva. Report history of swelling, fever, or mumps exposure.
Specimen: Serum (SST, 2-5 mL), Saliva (sterile container, 1-2 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document swelling, fever, parotitis, or mumps exposure. Include current medications, especially antivirals or immunosuppressants.
Consent: Written consent required, detailing the tests purpose, mumps infection implications, and risks of sample collection.
Procedural Considerations: Uses immunoassay to detect mumps IgM in serum or saliva. Results are available in 1-2 days, supporting rapid clinical decisions. Performed in laboratories, often for acute mumps diagnosis.
Factors Affecting Result Accuracy: Hemolysis, lipemia, or improper sample storage can affect results. Early infection may yield false negatives.
Clinical Significance: Positive mumps IgM confirms recent infection, guiding supportive care or isolation measures. Negative results may require PCR testing.
Specialist Consultation: Consult an infectious disease specialist for result interpretation and treatment planning.
Additional Supporting Tests: Mumps PCR, IgG test, or throat swab to confirm mumps diagnosis.
Test Limitations: Early infection may yield false negatives; clinical correlation is needed. Cross-reactivity with other viruses may occur.
References: CDC Mumps Guidelines, 2023; Clinical Infectious Diseases, Rubin SA, 2022.
